MusicAnx-SSPI: Impact of Listening to Music on Anxiety Postoperative in a Postanesthesic Care Unit (PACU) After Spinal Anesthesia

Sponsor
CHU de Reims (Other)
Overall Status
Recruiting
CT.gov ID
NCT05002257
Collaborator
(none)
200
1
2
15.2
13.1

Study Details

Study Description

Brief Summary

Our hypothesis is that listening to music has a beneficial effect on the French population receiving spinal anesthesia for a scheduled procedure. We think we can reduce anxiety when switching to SSPI, using creative music therapy software (Music Care) French validated by clinical research.

Condition or Disease Intervention/Treatment Phase
  • Other: music therapy
  • Other: No music therapy
N/A

Detailed Description

We want to demonstrate that listening to music:
  • decreases the anxiety of patients in PHC;

  • improves their overall satisfaction unlike patients subjected to ambient noise from the SSPI. Demonstrate that there is a link between trait anxiety assessed preoperatively and state anxiety assessed immediate postoperative period to anticipate and improve patient care as soon as they arrive in SSPI. Extend music listening to all patients staying in a postoperative SSPI or for procedures performed in SSPI (bladder probing, central venous approach, post locoregional analgesia operative…) The Music Care software that we have chosen to use has been specifically developed to use the music as a therapeutic aid. Numerous abstracts and clinical studies have been published on the subject the use of this software in reducing anxiety, pain, behavioral and changes in hemodynamic parameters. It is based on the use of the so-called "U" method, which is a relaxation method based on hypno-analgesia, thus offering a complete relaxation session to patient.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Impact of Listening to Music on Anxiety Postoperative in a Postanesthesic Care Unit (PACU) After Spinal Anesthesia
Actual Study Start Date :
May 25, 2021
Anticipated Primary Completion Date :
May 25, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Arm

Other: music therapy
Patients included in the intervention arm with music therapy will choose among 3 possible music: music from elsewhere, classical music, today's music. These 3 music thearpy will have an identical duration of 20 minutes.

Active Comparator: Control arm

Other: No music therapy
Usual care

Outcome Measures

Primary Outcome Measures

  1. anxiety postoperative in a postanesthesic care unit (PACU) after spinal anesthesia [Day 0]

    Anxiety is assess by using Spielberg's STAI-Ya from 20 (no anxiety) to 80 (anxiety)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

inclusion criteria :

  • adult patients;

  • undergoing scheduled orthopedic surgery, under spinal anesthesia;

  • non-cancerous, functional;

  • in traditional or outpatient hospitalization;

  • requiring a passage in PACU;

  • agreeing to participate in the study (consent form).

exclusion criteria :

  • Children;

  • under tutorship or curatorship;

  • having known hearing problems (hearing loss or not, deafness) reported during the anesthesia consultation or detected during the collection of preoperative data; having cognitive disorders (dementia, disorientation) reported during the consultation of anesthesia, not allowing questions to be answered

  • Patients equipped with their personal music.

The following will be excluded when they arrive in SSPI:
  • Patients who received a benzodiazepine during the intraoperative period;

  • Patients whose spinal anesthesia has been converted to general anesthesia;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Damien JOLLY Reims France

Sponsors and Collaborators

  • CHU de Reims

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CHU de Reims
ClinicalTrials.gov Identifier:
NCT05002257
Other Study ID Numbers:
  • PP21063
First Posted:
Aug 12, 2021
Last Update Posted:
Nov 30, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by CHU de Reims
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2021